Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (4): 835-841    DOI: 10.31083/j.ceog4804133
Original Research Previous articles | Next articles
Age and anti-Műllerian hormone: prediction of cumulative pregnancy outcome in in vitro fertilization with diminished ovarian reserve
Yu Deng1, Zhan-Hui Ou1, Min-Na Yin1, Pei-Ling Liang1, Zhi-Heng Chen1, Abraham Morse1, Ling Sun1, *()
1Center of Reproductive Medicine, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 510623 Guangzhou, China
Download:  PDF(416KB)  ( 57 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: To determine the effects of AMH and age on IVF outcomes in women with DOR and whether the cumulative pregnancy potential after consecutive IVF cycles is age or AMH level depended. Methods: Between January 2014 and December 2018, 466 infertility patients (1004 IVF/ICSI cycles) with AMH ≤1.1 ng/mL were recruited and firstly divided into two groups (Group 1: AMH <0.6 ng/mL and Group 2: AMH 0.6–1.1 ng/mL). Furthermore, they were stratified into another four groups (A1, A2; B1, B2) based on age (Group A: <38 y, Group B: ≥38 y). Laboratory parameters and cumulative pregnancy chances were retrospectively evaluated. Results: Regardless of age, number of retrieved oocytes, 2 pronuclear zygotes (2PN), embryos, good-quality embryos per cycle, implantation rate (IR), clinical pregnancy rate (CPR) and ongoing pregnancy rate (OPR) per embryo transfer (ET) and per patient were significantly lower in Group 1 than those in Group 2 (P < 0.001). However, in women <38 years, there were no significant differences in IR, CPR and OPR per ET and per patient between Group A1 and A2 (P > 0.05). The cumulative OPR per patient increased to 60% in Group A2 and 51.7% in Group A1 after the third transfer but reached a plateau (24.8% in Group B2 and 11.8% in Group B1) after the second ET. Conclusions: For advanced-age women with DOR, AMH level showed as a strong predictor of both ovarian response and pregnancy rate. However, even with extremely lower AMH value, younger women still had higher potential to get pregnancy chance through more attempts at subsequent IVF treatments.
Key words:  Age      Anti-Műllerian hormone      Diminished ovarian reserve      IVF      Ongoing pregnancy rate     
Submitted:  12 November 2020      Revised:  10 December 2020      Accepted:  23 December 2020      Published:  15 August 2021     
Fund: 
17020150684/Chinese Medical Association
20211A011026/Health Science and technology project of Guangzhou
20201A011029/Health Science and technology project of Guangzhou
*Corresponding Author(s):  sunling6299@163.com; sunling6299@gwcmc.org (Ling Sun)   

Cite this article: 

Yu Deng, Zhan-Hui Ou, Min-Na Yin, Pei-Ling Liang, Zhi-Heng Chen, Abraham Morse, Ling Sun. Age and anti-Műllerian hormone: prediction of cumulative pregnancy outcome in in vitro fertilization with diminished ovarian reserve. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 835-841.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog4804133     OR     https://ceog.imrpress.com/EN/Y2021/V48/I4/835

[1] Amanda M. Wang, Alan J. Lee, Shannon M. Clark. The effects of overweight and obesity on pregnancy-related morbidity[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 999-1009.
[2] Pelin Kutlu, Seda Karabulut, Oya Korkmaz. Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1025-1031.
[3] Sarah Ottum, Conrad Chao, Sejal Tamakuwala, Joshua Dean, Adib Shafi, Katherine Jennifer Kramer, Satinder Kaur, Maurice-Andre Recanati. Can ACGME Milestones predict surgical specialty board passage: an example in Obstetrics and Gynecology[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1048-1055.
[4] Sung-Hee Yang, Chul-Hwan Hwang, Hyun-Sook An, Dong-Yeon Lee. Proposal of reference values for transverse cerebellar diameter in Korean fetuses and comparison with other countries[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1056-1060.
[5] Caterina Pizzicaroli, Veronica Arciero, Ilaria Simonelli, Nicola Caporale, Massimo Maria Salvatori, Doriana Scaldaferri, Silvio Tartaglia, Giovanni Larciprete. Comparative assessment of Arabin pessary and cervical cerclage in the management of cervical insufficiency[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1111-1116.
[6] Min Jung Kim, Hee-Sook Lim, Hae-Hyeog Lee, Tae-Hee Kim, Yongsoon Park. Dietary assessment, nutrition knowledge, and pregnancy outcome in high-risk pregnant Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1178-1185.
[7] Aybike Pekin, Ayşe Gül Kebapçılar, Ersin Çintesun, Setenay Arzu Yılmaz, Özlem Seçilmiş Kerimoğlu. Comparison of an estradiol patch and GnRH-antagonist protocol with a letrozole/antagonist protocol for patients without oocyte development, fertilization and/or embryo development in previous IVF cycles[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 924-928.
[8] Nur Dokuzeylul Gungor, Kagan Güngör, Mustecep Kavrut, Arzu Yurci. A retrospective series of homologous intracytoplasmic sperm injection cycle results of 99 women with mosaic Turner syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 942-948.
[9] Dominik Jakubowski, Daria Salloum, Marek Maciejewski, Magdalena Bednarek-Jędrzejek, Anna Kajdy, Aneta Cymbaluk-Płoska, Ewa Kwiatkowska, Andrzej Torbé, Sebastian Kwiatkowski. Comparison of application of Fenton, Intergrowth-21st and WHO growth charts in a population of Polish newborns[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 949-954.
[10] Qian Hu, Mohammed Sharooq Paramboor, Tao Guo. Diagnosis and management of intramural ectopic pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 974-979.
[11] Xue-Li Bai, Xia Cao. Postpartum hemorrhage and prolonged hyperfibrinolysis as complications of uterine cavernous hemangioma: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 987-990.
[12] Fikret Salık, Mustafa Bıçak. Can requirement for blood transfusion be predicted before delivery? Analysis of risk factors for blood transfusion in patients with postpartumhemorrhage[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 572-577.
[13] Keiko Nemoto Murofushi, Reiko Tanaka, Ayako Ohkawa, Haruko Numajiri, Toshiyuki Okumura, Hideyuki Sakurai. Outcomes and dose—volume parameters for computed tomography-based brachytherapy planning for vaginal recurrence of uterine cancer primarily treated with surgery[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 601-606.
[14] Gulzhanat Aimagambetova, Aiym Kaiyrlykyzy, Gauri Bapayeva, Talshyn Ukybassova, Kamila Kenbayeva, Bakytkali Ibrayimov, Alla Lyasova, Giulio Bonaldo, Giovanni Buzzaccarini, Marco Noventa, Antonio Simone Laganà, Milan Terzic. Validation of Pipelle endometrial biopsy in patients with abnormal uterine bleeding in Kazakhstani healthcare setting[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 670-675.
[15] Guy Shrem, Nouf M. Alasmari, Jacques Balayla, Alexander Volodarsky-Perel, Weon-Young Son, Michael H. Dahan. Paternal age predicts live birth in women above 40 years of age undergoing in-vitro fertilization (IVF)[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 299-306.
No Suggested Reading articles found!